IPHA•benzinga•
HC Wainwright & Co. Reiterates Buy on Innate Pharma, Lowers Price Target to $11
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 24, 2025 by benzinga